Trends in Hospitalization of Children with Bacterial Pneumonia in Poland

Małgorzata Gajewska1, Katarzyna Lewtak1, Jacques Scheres2,3

  • 1Department of Health Promotion and Postgraduate Education, National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland.

Insights

Hospitalization for bacterial pneumonia in Polish children aged 0-6 increased significantly from 2007-2011. Younger children experienced longer hospital stays, highlighting the need for increased pneumococcal vaccinations.

Area of Science:

  • Pediatrics
  • Public Health
  • Infectious Diseases

Background:

  • Bacterial pneumonia poses a significant public health risk, particularly for infants.
  • Trends in pediatric bacterial pneumonia hospitalizations require ongoing monitoring.

Purpose of the Study:

  • To analyze hospitalization trends for bacterial pneumonia in children aged 0-6 in Poland between 2007 and 2011.
  • To identify age-specific hospitalization rates and average length of stay.

Main Methods:

  • Retrospective analysis of hospitalization data for children aged 0-6.
  • Data categorized using ICD-10 codes J13-J15.
  • Analysis of hospitalization rates and length of stay over a five-year period.

Main Results:

  • Hospitalization rates for bacterial pneumonia increased from 2007 to 2011 in both boys and girls.
  • Children aged 1-2 years had the highest hospitalization rates.
  • Average length of stay decreased during the study period, with the youngest children having the longest stays.

Conclusions:

  • Bacterial pneumonia remains a critical public health concern in pediatric populations.
  • Increased vaccination against Streptococcus pneumoniae is recommended in Poland.
  • Targeted interventions for high-risk age groups may be necessary.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...